January 9, 2012
CARLSBAD, Calif. and SAN FRANCISCO -- Life Technologies Corporation (NASDAQ: LIFE) today announced several new products and protocols to improve workflows for Ion Torrent DNA sequencing applications, demonstrating the unparalleled speed, scalability and simplicity that Ion Torrent delivered in 2011. "In 2011 we scaled semiconductor sequencing 100x and simplified the workflow with Ion OneTouch ™," [...]
Agilent Technologies Announces Launch of the World’s First Triple Quadrupole ICP-MS
January 9, 2012
SANTA CLARA, Calif.--Agilent Technologies Inc. (NYSE:A) today announced the launch of the Agilent 8800 triple quadrupole ICP-MS (ICP-QQQ), the first and only instrument of its kind. The new ICP-QQQ system offers improved performance compared to single quadrupole ICP-MS, and provides MS/MS operation for controlled and consistent interference removal in reaction mode. ICP-QQQ also addresses high-end [...]
American Auto-Matrix Resolves Patent Infringement Lawsuit Against TSI Incorporated
January 9, 2012
EXPORT, Pa. -- American Auto-Matrix today announced that it resolved its patent infringement lawsuit against TSI Incorporated with an amicable and mutually beneficial settlement. The lawsuit, which had been pending in federal court since May 17, 2010, involved AAM's U.S. Patent number 5,764,579, entitled "System for Controlling Laboratories with Fume Hoods." This patent broadly covers [...]
Knome Expands Scientific Advisory Board
January 9, 2012
CAMBRIDGE, Mass.--Knome, Inc., the human genome interpretation company, today announced that it has expanded its scientific advisory board to include two respected experts in genomics, Dr. David Goldstein of Duke University and Dr. Yaniv Erlich of the Whitehead Institute for Biomedical Research. “We are very pleased to appoint two highly talented genomics experts to our [...]
Knome Appoints Martin Tolar as Chief Executive Officer
January 9, 2012
CAMBRIDGE, MA – Knome, Inc., the human genome interpretation company, today announced that it has appointed Martin Tolar, MD, PhD, as the company’s Chief Executive Officer. In addition, Knome has expanded the management team as the company pursues new growth opportunities to interpret and apply genomic information across the healthcare community—including academic researchers, drug companies, [...]
January 9, 2012
SAN DIEGO -- Gen-Probe's (NASDAQ: GPRO) multiple new product launches are off to a good start and should help drive accelerating, double-digit revenue growth in 2012, according to Carl Hull, Gen-Probe's chairman and CEO, who will discuss the Company's 2011 accomplishments and future strategies with investors at JP Morgan's 30th annual healthcare conference in San [...]
January 9, 2012
HILDEN and BERLIN, Germany - QIAGEN N.V. and the Max Planck Institute for Infection Biology (MPIIB), Department of Immunology have announced a new collaboration to develop a molecular diagnostic test to assess the risk of an individual with latent tuberculosis (TB) developing active TB disease during their lifetime. Financial terms were not disclosed. Approximately one-third [...]
Expanded Range of Tissue Culture Treated Microplates
January 9, 2012
Porvair Sciences has expanded its range of tissue culture treated clear bottomed microplates. Now available in 6-, 12-, 24- and 96-well formats - the bottom surface of Porvair tissue culture treated microplates is treated to enhance cellular attachment and growth in uniform layers. These high quality, clear bottomed plates allow cells grown on their bottom [...]
January 9, 2012
OMAHA, Neb. & THE WOODLANDS, Texas-- Transgenomic, Inc. (OTCBB: TBIO) and Power3 Medical Products, Inc. (OTCBB: PWRM) today announced that, following mediation through the offices of the United States District Court for the District of Nebraska, all pre-existing litigations and disputes between the companies have been resolved and terminated, effective immediately. The dispute related to [...]
Sequenom Announces 2011 Operational Highlights and Early 2012 Outlook
January 8, 2012
AN DIEGO -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced highlights of the Company's 2011 performance and accomplishments, as well as preliminary activities and goals for the first part of 2012. Initial 2011 Performance Results Total revenue growth of approximately 23 percent year-over-year for 2011 (unaudited). Over [...]

